Infektionsbiologie

Zipfel PF, Zipfel S, Wiech T (2023) [Role of Complement in Kidney Diseases - New Aspects]. Dtsch Med Wochenschr 148(12), 774-779.

Chen LY, Schirmer U, Widder M, Gruel Y, Rollin J, Zipfel PF, Nguyen TH (2022) Breast cancer cell-based ELISA: a potential material for better detection of heparin-induced thrombocytopenia antibodies. J Mater Chem B 10(38), 7708-7716.

Chen Y, Dahse HM, Paetz, C, Schneider B (2022) Precursor-directed synthesis of apoptosis-initiating N-hydroxyalkyl phenylbenzoisoquinolindione alkaloids. ChemistryOpen 11(12), e202200157.

Erdenetsogt U, Nadmid S, Paetz C, Dahse HM, Voigt K, Gotov C, Boland W, Dagvadorj E (2022) New guaianolide sesquiterpene lactones and other constituents from Pyrethrum pulchrum. Planta Med 88(5), 380-388.

Garcia KYM, Quimque MTJ, Lambert C, Schmidt K, Primahana G, Stradal TEB, Ratzenböck A, Dahse HM, Phukhamsakda C, Stadler M, Surup F, Macabeo APG (2022) Antiproliferative and cytotoxic cytochalasins from Sparticola triseptata inhibit actin polymerization and aggregation. J Fungi (Basel) 8(6), 560.

Halder LD, Babych S, Palme DI, Mansouri-Ghahnavieh E, Ivanov L, Ashonibare V, Langenhorst D, Prusty B, Rambach G, Wich M, Trinks N, Blango MG, Kornitzer D, Terpitz U, Speth C, Jungnickel B, Beyersdorf N, Zipfel PF, Brakhage AA, Skerka C (2022) Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth. mBio 13(1), e0356321.

Ruiz-Molina N, Parsons J, Müller M, Hoernstein SNW, Bohlender LL, Pumple S, Zipfel PF, Häffner K, Reski R, Decker EL (2022) A synthetic protein as efficient multitarget regulator against complement over-activation. Commun Biol 5(1), 152.

Schieferdecker S, Bernal FA, Wojtas KP, Keiff F, Li Y, Dahse HM, Kloss F (2022) Development of predictive classification models for whole cell antimycobacterial activity of benzothiazinones. J Med Chem 65(9), 6748-6763.

Schmidt T, Afonso S, Perie L, Heidenreich K, Wulf S, Krebs CF, Zipfel PF, Wiech T (2022) An interdisciplinary diagnostic approach to guide therapy in C3 glomerulopathy. Front Immunol 13, 826513.

Shahraz A, Lin Y, Mbroh J, Winkler J, Liao H, Lackmann M, Bungartz A, Zipfel PF, Skerka C, Neumann H (2022) Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway. Sci Rep 12(1), 5818.